PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients Read more
AbCellera Closes $105 Million Series B Financing to Further Advance World-Leading Antibody Drug Discovery Platform Read more
EdiGene and Immunochina Announce R&D Collaboration to Develop Allogeneic CAR-T Therapy for Cancer Read more
Thermo Fisher Scientific Extends Collaboration with Biognosys to Enhance Protein Quantitation Mass Spectrometry Workflows Read more
Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab Read more
NOVASEP And LYSOGENE Announce Their New Collaboration For Development And Production Of GM1 Gangliosidosis Gene Therapy Product Read more